Tatsis Ourania 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Dec 5, 2025
Insider Transaction Report
Form 4
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
Transactions
- Sale
Common Stock
2025-12-03$449.99/sh−4,500$2,024,955→ 46,793 total
Footnotes (3)
- [F1]Transaction made pursuant to Dr. Tatsis' company approved trading plan under Rule 10b5-1, which was entered into on 08/21/2025.
- [F2]Open market sales reported on this line occurred at a weighted average price of $449.99 (range $449.99 to $450.00).
- [F3]Dr. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.